Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change
26-09-25	€0.6400	0.00%
26-09-24	€0.6400	0.00%
26-09-23	€0.6400	0.00%
26-09-22	€0.6400	0.00%
26-09-21	€0.6400	0.00%

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 11:55:00 2026-09-25 EDT			5-day change	1st Jan Change
0.6400 ^EUR	0.00%		0.00%	-63.43%

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 145K 120K 110K 205K 13.93M 207K 1.44M 558K 7.12M 546K 534K 22.87M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.09M 12.5M 11.4M 21.33M 1.45B 21.48M 150M 57.96M 739M 56.65M 55.42M 2.37B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALSAF	Real-time
Deutsche Boerse AG	OR9	Delayed
Börse Stuttgart	OR9	Delayed

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan

Safe S.A. Stock

Stocks

ALSAF

FR001400ZU25

Medical Equipment, Supplies & Distribution

Valuation: Safe S.A.

Chart: Safe S.A.

Latest news: Safe S.A.

Press Releases: Safe S.A.

News in other languages: Safe S.A.

Quotes and Performance

Price Extremes

Managers and Directors: Safe S.A.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

09-08	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
08-25	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

1 week	0.64	0.64
1 month	0.64	0.64
Current year	0.54	1.81
1 year	0.54	2.6
3 years	0.54	141,014.1
5 years	0.54	5,572,199,944.28
10 years	0.54	10,000,000,000

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE S.A.	0.00%	0.00%	-73.33%	-100.00%	145K
STRYKER CORPORATION	+0.97%	-1.00%	-26.10%	-5.23%	104B
SMITH & NEPHEW PLC	+0.35%	-1.90%	-23.58%	-3.12%	11.23B
GLAUKOS CORPORATION	-0.29%	-5.73%	+89.55%	+102.21%	9.1B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.29%	+3.12%	-49.04%	-67.22%	4.14B
DOUBLE MEDICAL TECHNOLOGY INC.	-0.91%	+6.44%	-25.51%	+26.97%	2.49B
INSPIRE MEDICAL SYSTEMS, INC.	+2.46%	-8.18%	-8.82%	-61.91%	2.04B
INSIGHT LIFETECH CO., LTD.	-3.28%	+0.48%	-	-	1.94B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-1.43%	+0.29%	-24.06%	-32.26%	1.53B
Average	-0.38%	-0.72%	-17.61%	-17.57%	15.22B
Weighted average by Cap.	+0.67%	-1.20%	-18.50%	-0.28%

	2024	2025
Net sales	5.04M 5.74M 4.76M 4.34M 8.12M 551M 8.18M 56.97M 22.07M 281M 21.57M 21.1M 904M	5.36M 6.11M 5.07M 4.62M 8.64M 586M 8.7M 60.62M 23.48M 299M 22.95M 22.45M 962M
Net income	-1.93B -2.2B -1.82B -1.66B -3.11B -211B -3.13B -21.81B -8.45B -108B -8.26B -8.08B -346B	-4.67M -5.33M -4.41M -4.02M -7.53M -511M -7.58M -52.83M -20.46M -261M -20M -19.57M -838M
Net Debt	11.47M 13.07M 10.83M 9.87M 18.48M 1.25B 18.61M 130M 50.21M 640M 49.08M 48.02M 2.06B	13.11M 14.94M 12.38M 11.29M 21.13M 1.43B 21.28M 148M 57.4M 732M 56.1M 54.89M 2.35B

3 months	+6.67%
6 months	-20.99%
Current year	-63.43%